Search
Life Sciences Regulatory Overview In this episode, we explore the complex regulatory landscape of the life sciences industry, providing attorneys with critical insights into the compliance requirements that govern pharmaceuticals, medical devices, and diagnostics. Whether you advise biotech startups...
Life Sciences Industry Basics This episode provides attorneys with a comprehensive foundation in the life sciences industry, equipping legal professionals with the knowledge needed to navigate this complex and highly regulated sector. Whether you advise pharmaceutical companies, biotech startups, or...
On October 7, 2024, the New Jersey Board of Public Utilities (the “Board”) issued a Notice of Proposed Substantial Changes to its previously proposed Community Solar Energy Program regulations (the “Proposed Changes”). The notice addresses prior comments and issues changes to the Board’s September...
BALTIMORE, (JUNE 12, 2024) – In joining Saul Ewing as a new partner, Carville B. Collins brings the firm’s clients more than 30 years of experience representing energy, water and other regulated businesses seeking a wide array of approvals from Maryland regulators. His practice also includes work in...
Understanding the complex intersection of environmental regulations intended to combat climate change between now and 2050 while responding to the U.S. tech economy’s exponential growth in energy demand will require collaboration between consumers, industry and government, and reliance upon a...
“PFAS” is an acronym for per- and polyfluoroalkyl substances, a family of thousands of widely used manmade chemicals that resist grease, oil, water and heat. PFAS has been used in firefighting foams, protective coatings and stain-resistant garments and carpets. PFAS are mobile and persistent; they...
PCI, in partnership with Penn Medicine, is pleased to co-host a commercialization speaker series geared toward Penn Medicine faculty, researchers and students. Each session will feature an expert guest speaker as well as time for questions and discussion. The first session will discuss the latest...
Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...